Status:
RECRUITING
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Lead Sponsor:
National University Hospital, Singapore
Collaborating Sponsors:
National University of Singapore
Conditions:
Cardiovascular Diseases
Metabolic Syndrome
Eligibility:
All Genders
40-70 years
Brief Summary
Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health res...
Eligibility Criteria
Inclusion
- 40-70 years old
- ASCVD (atherosclerotic cardiovascular disease) score of 5% and higher
Exclusion
- Previous major cardiovascular disease (myocardial infarction, heart failure, ischemic stroke)
- Limited life expectancy
- Other ongoing unstable medical conditions
- Pregnant women
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT06211868
Start Date
March 1 2024
End Date
September 1 2030
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NUS
Singapore, Singapore